Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in advanced urothelial cancer.

Karen Giselle Chee1, Angelo Cambio, Primo N Lara

  • 1University of California Davis Cancer Center, Sacramento, 95817, USA. Karen.chee@ucdmc.ucdavis.edu

Current Opinion in Urology
|August 12, 2005
PubMed
Summary

Advanced bladder cancer treatment is evolving. While platinum-based chemotherapy remains standard, new regimens and diagnostic technologies offer hope for improved urothelial cancer management and patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer.

Nanomedicine (London, England)·2026
Same author

A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.

Nanomedicine (London, England)·2026
Same author

Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma.

Current problems in cancer·2026
Same author

Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in California.

Cancer research communications·2026
Same author

Targeting Wnt/β-catenin and circadian regulator restores PRC2/EZH2-controlled chromatin bivalency and suppresses cell state diversity.

The Journal of clinical investigation·2026
Same author

Cancer statistics, 2026: Charting a course for a national cancer research agenda.

CA: a cancer journal for clinicians·2026

Area of Science:

  • Oncology
  • Urology

Background:

  • Metastatic or unresectable urothelial cancer traditionally treated with platinum-based chemotherapy.
  • Long-term survival data and toxicities necessitate novel treatment options.

Purpose of the Study:

  • Summarize recent developments in advanced bladder cancer diagnosis and management.
  • Review novel treatment options and diagnostic advancements for urothelial cancer.

Main Methods:

  • Review of recent clinical trials (circa 2004) on chemotherapy combinations.
  • Analysis of advances in imaging and laboratory technologies for cancer prognostication.

Main Results:

  • New chemotherapy combinations, including platinum-containing and platinum-free regimens, have been investigated.

Related Experiment Videos

  • No new regimens have demonstrated superiority over cisplatin-based treatments.
  • Advances in diagnostics offer improved understanding of urothelial cancer behavior and prognosis.

    • Conclusions:

    • Ongoing research explores novel chemotherapy and diagnostic approaches for advanced bladder cancer.
    • Improved diagnostic tools may enhance patient selection for therapy.
    • Further research is needed to establish superior treatment strategies for urothelial cancer.